From the source
Amazon's walkthrough shows drug discovery teams how to deploy OpenFold3-preview, an open source biomolecular structure prediction model, from SageMaker JumpStart into their own AWS accounts.
- The OpenFold Consortium and the AlQuraishi Lab at Columbia University developed the model, which predicts the joint 3D structure of proteins, DNA, RNA, small-molecule ligands and the complexes they form in a single prediction.
- Because folding time grows with the number and length of chains and real-world complexes often take several minutes, the model runs on SageMaker Asynchronous Inference rather than a real-time endpoint, which caps requests at 60 seconds.
- Requests go to Amazon S3 and are invoked with InvokeEndpointAsync, with an invocation timeout of up to 1 hour and results written to an S3 location the user chooses.
- The endpoint queues bursts of requests internally and can scale to zero instances when the queue is empty, which Amazon says helps avoid paying for idle instances between experiments.
- The endpoint runs with network isolation, and users can supply their own multiple sequence alignments to improve accuracy while helping keep sequences private.
- The developers release the code and model weights under the Apache 2.0 license and describe OpenFold3-preview as a research preview; Amazon notes endpoints are billed per instance-hour while running, including while idle.






